In vitro and animal models have found estrogens to promote lung tumor growth; further, estrogen receptor antagonists were shown to significantly inhibit the growth of nonsmall cell lung cancer cell lines.[13] A later age at menarche in effect implies postponement of the estrogen surge that may serve to decrease the risk of lung cancer. Here, ESR1 is linked to lung carcinoma.